Financial

Wright Medical Group Price Target Cut to $26.00 by Analysts at BMO Capital Markets (WMGI)

By Samantha Reynolds

Wright Medical Group (NASDAQ:WMGI) had its price target decreased by BMO Capital Markets from $30.00 to $26.00 in a research report report published on Friday, StockTargetPrices.com reports.

Other equities research analysts also recently issued reports about the company. Brean Capital reiterated a buy rating and issued a $38.00 price target on shares of Wright MedicalGroup in a report on Wednesday, September 2nd. Northland Securities restated a buy rating and set a $32.00 price objective on shares of Wright Medical Group in a research note on Wednesday, September 2nd. Zacks upgraded Wright Medical Group from a sell rating to a hold rating in a research report on Wednesday, July 15th. Piper Jaffray restated a hold rating and issued a $27.00 price objective on shares of Wright Medical Group in a report on Wednesday, September 2nd. Finally, Needham & Company LLC reaffirmed a hold rating on shares of Wright Medical Group in a report on Thursday, August 20th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and an average target price of $31.42.

In other news, insider Kevin D. Cordell sold 1,778 shares of the stock in a transaction that occurred on Wednesday, October 7th. The stock was sold at an average price of $20.37, for a total value of $36,217.86. Following the completion of the transaction, the insider now directly owns 5,924 shares of the company’s stock, valued at approximately $120,671.88. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Lance A. Berry sold 5,146 shares of the stock in a transaction that occurred on Wednesday, October 7th. The stock was sold at an average price of $20.37, for a total value of $104,824.02. Following the completion of the transaction, the chief financial officer now directly owns 57,950 shares of the company’s stock, valued at $1,180,441.50. The disclosure for this sale can be found here.

Related Articles

Back to top button